Literature DB >> 15642786

Identification of alpha-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex.

Weiye Wang1, Lishan Wang, Akira Endoh, Geoffrey Hummelke, Christina L Hawks, Peter J Hornsby.   

Abstract

In order to establish whether there are differences in DNA-binding proteins between zona fasciculata (ZF) and zona reticularis (ZR) cells of the human adrenal cortex, we prepared nuclear extracts from separated ZF and ZR cells. The formation of DNA-protein complexes was studied using an element in the first intron of the type I and type II 3beta-hydroxysteroid dehydrogenase genes (HSD3B1 and HSD3B2). Using the element in the HSD3B2 gene as a probe, a complex (C1) was formed with extracts from ZF cells but was formed only at a low level with ZR cell extracts. Another pair of complexes (C2/C3) was formed with both ZF and ZR cell extracts. The ZF-specific protein forming C1 was enriched by column chromatography on DEAE-Sepharose and carboxymethyl-Sepharose. Oligonucleotide competition analysis on the enriched fraction gave results consistent with those obtained on the unfractionated material. A further enrichment was brought about by passing the protein over an oligonucleotide affinity column based on the HSD3B2 element. The protein bound to the column was identified as alpha-enolase by mass spectrometry. Although alpha-enolase is a glycolytic enzyme, it binds to specific DNA sequences and has been found to be present in nuclei of various cell types. We performed immunohistochemistry on sections of adult human adrenal cortex and found alpha-enolase to be located in nuclei of ZF cells but to be predominantly cytoplasmic in ZR cells. Transfection of an alpha-enolase expression vector into NCI-H295R human adrenocortical cells increased HSD3B2 promoter activity, suggesting a possible functional role for this protein in regulation of HSD3B2 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642786     DOI: 10.1677/joe.1.05909

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  16 in total

Review 1.  Single-gene disorders: what role could moonlighting enzymes play?

Authors:  Ganesh Sriram; Julian A Martinez; Edward R B McCabe; James C Liao; Katrina M Dipple
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

2.  Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea.

Authors:  Maura Rojas-Pirela; Diego Andrade-Alviárez; Verónica Rojas; Ulrike Kemmerling; Ana J Cáceres; Paul A Michels; Juan Luis Concepción; Wilfredo Quiñones
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

3.  Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate.

Authors:  Wenjia Gan; Guoxiong Zhao; Hongxu Xu; Weihua Wu; Wuying Du; Jiang Huang; Xinbing Yu; Xuchu Hu
Journal:  Parasitol Res       Date:  2010-02-02       Impact factor: 2.289

4.  ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1.

Authors:  Tong Zhang; Linchong Sun; Yijie Hao; Caixia Suo; Shengqi Shen; Haoran Wei; Wenhao Ma; Pinggen Zhang; Ting Wang; Xuemei Gu; Shi-Ting Li; Zhaolin Chen; Ronghui Yan; Yi Zhang; Yongping Cai; Rongbin Zhou; Weidong Jia; Fang Huang; Ping Gao; Huafeng Zhang
Journal:  Nat Cancer       Date:  2021-12-09

5.  The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Yan-Hwa Wu Lee; Chi-Hong Chao; Kou-Juey Wu; Min-Jen Tseng; Tien-Shun Yeh
Journal:  Mol Cell Biol       Date:  2008-05-19       Impact factor: 4.272

6.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

7.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

8.  Effects of partial silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle on the enterance of human fibroblasts to the S phase.

Authors:  Aleksandra Konieczna; Aneta Szczepańska; Karolina Sawiuk; Grzegorz Węgrzyn; Robert Łyżeń
Journal:  BMC Cell Biol       Date:  2015-05-28       Impact factor: 4.241

9.  ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.

Authors:  Haaglim Cho; JungIn Um; Ji-Hyung Lee; Woong-Hee Kim; Wan Seok Kang; So Hun Kim; Hyung-Ho Ha; Yong-Chul Kim; Young-Keun Ahn; Da-Woon Jung; Darren R Williams
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

10.  Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.

Authors:  Veronica De Rosa; Mario Galgani; Antonio Porcellini; Alessandra Colamatteo; Marianna Santopaolo; Candida Zuchegna; Antonella Romano; Salvatore De Simone; Claudio Procaccini; Claudia La Rocca; Pietro Biagio Carrieri; Giorgia Teresa Maniscalco; Marco Salvetti; Maria Chiara Buscarinu; Adriana Franzese; Enza Mozzillo; Antonio La Cava; Giuseppe Matarese
Journal:  Nat Immunol       Date:  2015-09-28       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.